文献速递胸部肿瘤放疗姑息放疗与转移瘤

中央型肺肿瘤的立体定向体部放疗:我们的经验

Stereotactic body radiotherapy for central lung tumors, yes we can!
PubMed 文献 · Radiat Oncol · 2018-04-25

该研究回顾性分析了70例中央型肺肿瘤患者接受SBRT的治疗结果,包括早期NSCLC、局部复发和寡转移。中位随访18.3个月,局部失败率6%,中位OS 4.6年。结论认为中央型SBRT安全有效。

要点

  • 中央型肺肿瘤SBRT局部控制率好,局部失败率6%。
  • 中位总生存4.6年,毒性可接受,致命性出血1例。
  • 适用于再程放疗、术后复发和寡转移患者。

核心结论

  • 中央型肺肿瘤SBRT安全有效,可用于再程放疗、术后复发和寡转移患者。

研究设计与样本

  • 所有患者接受4DCT模拟,采用IMRT或VMAT技术计划,处方剂量覆盖95%等剂量线。

主要发现

  • 70例中早期NSCLC 13例,局部复发29例,肺寡转移28例。
  • 中位随访18.3个月,4/70例(6%)出现局部失败。
  • 全组中位OS为4.6年(CI 3-7年)。

临床怎么用

  • 对于中央型肺肿瘤,SBRT可作为再程放疗、术后复发和寡转移的治疗选择。

局限性

  • 回顾性研究,样本量70例,随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: SBRT is standard therapy for early stage lung cancer. Toxicity in central tumors has been a concern. RTOG 0813 showed that central SBRT is safe and effective. We report our experience with central SBRT. METHODS: We reviewed the records of patients treated with SBRT for central lung tumors (< 2 cm of the carina). Patients included primary lung cancer and recurrence following surgery and\ or conventional radiotherapy. All patients underwent 4DCT simulation and treatment planning was done with IMRT or VMAT techniques. Dose to the PTV was prescribed to the 95% isodose line. RESULTS: Seventy patients, between 5/09 and 4/13, were treated. Patients had early non-small cell lung cancer (n = 13) or locally recurrent lung cancer (n = 29) and pulmonary oligometastases (n = 28). Fifty-seven percent of the patients received BED of 132 with a schedule of 60Gy in 12 Gy fractions. Median follow up time was 18.3 months, 4/70 patients experienced local failure (6%). Median OS for the whole cohort was 4.6 years (CI 3-7 years). Ten patients had grade 1-2 radiation pneumonitis. One patient developed fatal bronchial bleeding. CONCLUSIONS: SBRT for central tumors is safe and effective in patients with central disease, reiradiation, recurrence following surgery and in oligometastes.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Korzets Ceder Y, Fenig E, Popvtzer A, et al. Stereotactic body radiotherapy for central lung tumors, yes we can! Radiat Oncol. 2018. PMID: 29695273. doi:10.1186/s13014-018-1017-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。